Human study · Aging · 2 Sept 2026
Reframing the epidemiological transition as increasing returns to tackling aging-related diseases
Source: Nature Aging
What the research found
Commentary. Ashwin, Bloom, Scott and colleagues argue that aging-related conditions now dominate disease burden across income groups, and that progress against them can compound. A population-health framing, not personal medical advice and not a claim that any product prevents disease.
Evidence level: Human study. A study in people, but an association isn't proof of cause.
More aging news
- In middle-aged male mice, an earlier loss of new tumor-fighting immune cells lined up with weaker melanoma control
- A commentary says telomere RNA loops can stall DNA copying and, in some tumors, get used to keep chromosome ends going
- After a long decline, heart-valve death rates in U.S. older adults rose from 2018 to 2023
- In adults over 50 followed for 24 years, a higher body mass index lined up with a faster drop in memory and thinking
- A lab force on bone extended lifespan in older mice through a signal called PEDF